Zelton Dave Sharp
3Patents
2h-index
8Co-inventors
30Inventor score
Filing activity: Aug 27, 2019 → Dec 2, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11110067B2 | Inhibition of mammalian target of rapamycin | Human Necessities | 6 | Active |
| US11191750B2 | Use of mTOR inhibitors for treatment of familial adenomatous polyposis | Human Necessities | 2 | Active |
| US12383538B2 | Use of mTOR inhibitors for prevention of intestinal polyp growth and cancer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.